Critical Care for Severe COVID-19: A Population-based Study from a Province with Low Case-fatality Rate in China
Xuelian Liao,Hong Chen,Bo Wang,Xiaodong Jin,Zhen Li,Zhongwei Zhang,Weimin Li,Jin Tang,Jian Wang,Rui Shi,Xiangde Zhen,Maojuan Wang,Xianying Lei,Yu Gong,Sheng Lv,Chao Jia,Li Chen,Juan Shang,Min Yang,Hailong Wei,Yuanjun Zhang,Xiong Yang,Huaqiang Shen,Xianhua Xiao,Jie Yang,Chang Liu,Qin Wu,Wen Wang,Jin Yang,Wanhong Yin,Xiaoqi Xie,Yongming Tian,Huan Liu,Bingxing Shuai,Wei Zhang,Xiangrong Song,Yan Kang
DOI: https://doi.org/10.1101/2020.03.22.20041277
2020-01-01
Abstract:Background Data regarding critical care for patients with severe COVID-19 are limited. We aimed to describe and analyse the clinical course, multi-strategy management, and respiratory support usage for the severe COVID-19 at the provincial level. Methods Using data from Sichuan Provincial Department of Health and the population-based multicentre cohort study, all microbiologically confirmed COVID-19 patients in Sichuan who met the national severe criteria were included from January 16 to March 15, 2020. All patients were followed-up from the day of inclusion, noted as Day one (D1), until discharge, death, or the end of the study. Findings Out of 539 COVID-19 patients, 81 severe cases (15.0%) were identified. The median (IQR) age was 50 (39-65) years, 37% were female, and 53.1% had chronic comorbidities. All severe cases were identified before requiring mechanical ventilation. Among the five predefined criteria for severe illness, low PaO2:FiO2 ratio (<300 mmHg) was the most commonly reported, accounting for 87.7% of the severe diagnosed. By establishing provisional ICUs, all 81 patients were admitted to hospitals capable of providing critical care, among whom 51 (63.0%) were treated in provisional ICUs. On D1, 77 patients (95.1%) were admitted, 76 (93.8%) were administered by respiratory support, including 51 (67.9%) by conventional oxygen therapy (COT). By D28, 53 (65.4%) were discharged, three (3.7%) were deceased, and 25 (30.9%) were still hospitalized. COT, administered to 95.1% of the patients, was the most commonly used respiratory support and met 62.7% of the respiratory support needed, followed by high-flow nasal cannula (19.5%) and non-invasive mechanical ventilation (10%). Interpretation The multi-strategy management for severe COVID-19 patients included early identification and timely critical care, including appropriate respiratory support in particular. Preparation of sufficient conventional oxygen equipment should be prioritized.